COMP <GO>
HNGE vs JKHY // REVENUE GROWTH (YOY)
Hinge Health Inc. (NYSE) VS. Jack Henry & Associates Inc. (NASDAQ) • 15-METRIC TALLY: HNGE 4
— JKHY 9
▲ REVENUE GROWTH (YOY) LEADER: HNGE
LAST: $114.32 (-2.21%) • MKT CAP: $9.43B
revenue-growth
50.60%
LAST: $161.34 (+1.08%) • MKT CAP: $11.19B
revenue-growth
7.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HNGE VS. JKHY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HNGE | JKHY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | 42.70% | +36.90 | HNGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.50% | -55.50 | JKHY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.81% | 5.26% | -3.45 | JKHY | /fcf-yield <GO> |
| Operating Margin | -60.00% | 23.90% | -83.90 | JKHY | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 19.20% | -79.20 | JKHY | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 50.60% | 7.20% | +43.40 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.47% | -1.47 | JKHY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.12 | 10.94 | +1.18 | HNGE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | JKHY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.5 | 57.3 | +13.20 | HNGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.24 | 1.32 | -0.08 | JKHY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 22.9x | +6.10 | JKHY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.43B | $11.19B | -$1.76B | JKHY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HNGE REV | JKHY REV | HNGE GROSS % | JKHY GROSS % | HNGE FCF | JKHY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $587.9M | $2.38B | 79.6% | 42.7% | $170.7M | $588.1M |
| FY 2024 | $390.4M | $2.22B | 76.8% | 41.3% | $48.0M | $509.9M |
| FY 2023 | $292.7M | $2.08B | — | — | -$77.1M | $288.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HNGE // BETA 1.24
JKHY // BETA 1.32